Apogee Therapeutics, Inc., (Nasdaq: APGE), a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest inflammatory and ...

The initiative will focus on sequencing bacterial genomes to understand their crucial roles in various sectors, including ...

Any big changes are bound to come with hurdles, but focusing on the benefits can help employers overcome these challenges.

The European Academy of Allergy and Clinical Immunology (EAACI) has launched the first World Anaphylaxis Awareness Day today ...

Our records of the human genome may still be missing tens of thousands of 'dark' genes. These hard-to-detect sequences of ...

Under the agreement, Biosion will receive over $40 million cash as an upfront license fee and reimbursement for certain development costs and drug product materials. Biosion said it will receive 19.9% ...

A fundraising event will take place today Friday, 22 November, and Saturday, 23 November, at the AHEPA NSW hall in Rockdale.

The initiative aims to explore and showcase India's unique microbial species, highlighting their roles in agriculture, the environment, and human health, while making genomic data freely available.

Presenter: Ruchi P. Patel, Ph.D., Research and Development Scientist Presentation Date and Time: Monday, December 9, 2024, 6:00 PM-8:00 PM PT ...

The risk for VTE was reduced among Military Health Systems beneficiaries who were vaccinated vs unvaccinated against COVID-19.

ATHENS, Greece, Nov. 13, 2024 (GLOBE NEWSWIRE) -- The European Academy of Allergy and Clinical Immunology (EAACI) is proud to announce the inaugural World Anaphylaxis Awareness Day on 21 November 2024 ...

PHILADELPHIA, PA — Vittoria Biotherapeutics will present groundbreaking research on its innovative Senza5™ platform at the 66th American Society of Hematology (ASH) Annual Meeting in San Diego, CA, ...